Glutaric acid-mediated apoptosis in primary striatal neurons

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Tian, Fengyan ^a,b   Fu, Xi ^a   Gao, Jinzhi ^a   Ying, Yanqin ^a   Hou, Ling ^a   Liang, Yan ^a   Ning, Qin ^a   Luo, Xiaoping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6 CYANO 7 NITROQUINOXALONE 2,3 DIONE; AMPA RECEPTOR ANTAGONIST; CASPASE 3; DIZOCILPINE; GLUTARIC ACID; LIPOCORTIN 5; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; UNCLASSIFIED DRUG; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GLUTARIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG RESPONSE; NERVE CELL; NONHUMAN; RAT; STRIATE CORTEX; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; ANIMAL; CELL CULTURE; CORPUS STRIATUM; DRUG EFFECTS; GENETICS; SPRAGUE DAWLEY RAT;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; APOPTOSIS; CASPASE 3; CELLS, CULTURED; CORPUS STRIATUM; GLUTARATES; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; UP-REGULATION;

EID: 84901759197     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/484731     Document Type: Article

References (39)

1. Kölker S., Garbade S. F., Greenberg C. R., Leonard J. V., Saudubray J.-M., Ribes A., Kalkanoglu H. S., Lund A. M., Merinero B., Wajner M., Troncoso M., Williams M., Walter J. H., Campistol J., Martí-Herrero M., Caswill M., Burlina A. B., Lagler F., Maier E. M., Schwahn B., Tokatli A., Dursun A., Coskun T., Chalmers R. A., Koeller D. M., Zschocke J., Christensen E., Burgard P., Hoffmann G. F., Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatric Research 2006 59 6 840 847 2-s2.0-33745106324 10.1203/01.pdr.0000219387.79887.86 (Pubitemid 44297640)
2. Funk C. B. R., Prasad A. N., Frosk P., Sauer S., Kölker S., Greenberg C. R., Del Bigio M. R., Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. Brain 2005 128 4 711 722 2-s2.0-16844385303 10.1093/brain/awh401 (Pubitemid 40516910)
3. Christensen E., Ribes A., Merinero B., Zschocke J., Correlation of genotype and phenotype in glutaryl-CoA dehydrogenase deficiency. Journal of Inherited Metabolic Disease 2004 27 6 861 868 2-s2.0-7244257508 10.1023/B:BOLI.0000045770.93429.3c (Pubitemid 39433621)
4. Jafari P., Braissant O., Bonafé L., Ballhausen D., The unsolved puzzle of neuropathogenesis in glutaric aciduria type I. Molecular Genetics and Metabolism 2011 104 4 425 437 2-s2.0-82255191631 10.1016/j.ymgme.2011.08.027
5. Magni D. V., Oliveira M. S., Furian A. F., Fiorenza N. G., Fighera M. R., Ferreira J., Mello C. F., Royes L. F. F., Creatine decreases convulsions and neurochemical alterations induced by glutaric acid in rats. Brain Research 2007 1185 1 336 345 2-s2.0-36448953931 10.1016/j.brainres.2007.09.023 (Pubitemid 350166317)
6. Latini A., Ferreira G. C., Scussiato K., Schuck P. F., Solano A. F., Dutra-Filho C. S., Vargas C. R., Wajner M., Induction of oxidative stress by chronic and acute glutaric acid administration to rats. Cellular and Molecular Neurobiology 2007 27 4 423 438 2-s2.0-34248545464 10.1007/s10571-006-9134-9 (Pubitemid 46763889)
7. Sauer S. W., Okun J. G., Fricker G., Mahringer A., Müller I., Crnic L. R., Mühlhausen C., Hoffmann G. F., Hörster F., Goodman S. I., Harding C. O., Koeller D. M., Kölker S., Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. Journal of Neurochemistry 2006 97 3 899 910 2-s2.0-33645881325 10.1111/j.1471-4159.2006.03813.x
8. Busanello E. N., Pettenuzzo L., Botton P. H., Neurodevelopmental and cognitive behavior of glutaryl-CoA dehydrogenase deficient knockout mice. Life Sciences 2013 92 2 137 142
9. Koeller D. M., Woontner M., Crnic L. S., Kleinschmidt-Demasters B., Stephens J., Hunt E. L., Goodman S. I., Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type 1. Human Molecular Genetics 2002 11 4 347 357 2-s2.0-0037084783 (Pubitemid 34213608)
10. Zinnanti W. J., Lazovic J., Housman C., Lanoue K., O'Callaghan J. P., Simpson I., Woontner M., Goodman S. I., Connor J. R., Jacobs R. E., Cheng K. C., Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I. Journal of Clinical Investigation 2007 117 11 3258 3270 2-s2.0-36048959139 10.1172/JCI31617 (Pubitemid 350096983)
11. +-ATPase and creatine kinase activities induced by acute lysine administration in glutaryl-CoA dehydrogenase deficient mice. Molecular Genetics and Metabolism 2012 107 1-2 81 86
12. Lamp J., Keyser B., Koeller D. M., Ullrich K., Braulke T., Mühlhausen C., Glutaric aciduria type 1 metabolites impair the succinate transport from astrocytic to neuronal cells. Journal of Biological Chemistry 2011 286 20 17777 17784 2-s2.0-79955947736 10.1074/jbc.M111.232744
13. Gerstner B., Gratopp A., Marcinkowski M., Sifringer M., Obladen M., Bührer C., Glutaric acid and its metabolites cause apoptosis in immature oligodendrocytes: a novel mechanism of white matter degeneration in glutaryl-CoA dehydrogenase deficiency. Pediatric Research 2005 57 6 771 776 2-s2.0-19444380168 10.1203/01.PDR.0000157727.21503.8D (Pubitemid 40727104)
14. Rosa R. B., Schwarzbold C., Dalcin K. B., Ghisleni G. C., Ribeiro C. A. J., Moretto M. B., Frizzo M. E. S., Hoffmann G. F., Souza D. O., Wajner M., Evidence that 3-hydroxyglutaric acid interacts with NMDA receptors in synaptic plasma membranes from cerebral cortex of young rats. Neurochemistry International 2004 45 7 1087 1094 2-s2.0-4444334755 10.1016/j.neuint.2004.05.001 (Pubitemid 39164933)
15. Ferreira G. C., Tonin A., Schuck P. F., Viegas C. M., Ceolato P. C., Latini A., Perry M. L. S., Wyse A. T. S., Dutra-Filho C. S., Wannmacher C. M. D., Vargas C. R., Wajner M., Evidence for a synergistic action of glutaric and 3-hydroxyglutaric acids disturbing rat brain energy metabolism. International Journal of Developmental Neuroscience 2007 25 6 391 398 2-s2.0-35748951029 10.1016/j.ijdevneu.2007.05.009 (Pubitemid 350051322)
16. Jafari P., Braissant O., Zavadakova P., Henry H., Bonafé L., Ballhausen D., Ammonium accumulation and cell death in a rat 3D brain cell model of glutaric aciduria type I. PLoS ONE 2013 8 1 e53735
17. Sauer S. W., Opp S., Mahringer A., Kamiński M. M., Thiel C., Okun J. G., Fricker G., Morath M. A., Kölker S., Glutaric aciduria type I and methylmalonic aciduria: simulation of cerebral import and export of accumulating neurotoxic dicarboxylic acids in in vitro models of the blood-brain barrier and the choroid plexus. Biochimica et Biophysica Acta. Molecular Basis of Disease 2010 1802 6 552 560 2-s2.0-77952242895 10.1016/j.bbadis.2010.03.003
18. Gao J., Zhang C., Fu X., Effects of targeted suppression of glutaryl-CoA dehydrogenase by lentivirus-mediated shRNA and excessive intake of lysine on apoptosis in rat striatal neurons. PLoS ONE 2013 8 5 e63084
19. Seminotti B., da Rosa M. S., Fernandes C. G., Amaral A. U., Braga L. M., Leipnitz G., de Souza D. O. G., Woontner M., Koeller D. M., Goodman S., Wajner M., Induction of oxidative stress in brain of glutaryl-CoA dehydrogenase deficient mice by acute lysine administration. Molecular Genetics and Metabolism 2012 106 1 31 38 2-s2.0-84860198994 10.1016/j.ymgme.2012.03.002
20. Keyser B., Glatzel M., Stellmer F., Kortmann B., Lukacs Z., Kölker S., Sauer S. W., Muschol N., Herdering W., Thiem J., Goodman S. I., Koeller D. M., Ullrich K., Braulke T., Mühlhausen C., Transport and distribution of 3-hydroxyglutaric acid before and during induced encephalopathic crises in a mouse model of glutaric aciduria type 1. Biochimica et Biophysica Acta. Molecular Basis of Disease 2008 1782 6 385 390 2-s2.0-43549096394 10.1016/j.bbadis.2008.02.008
21. Thies B., Meyer-Schwesingerb C., Lamp J., Acute renal proximal tubule alterations during induced metabolic crises in a mouse model of glutaric aciduria type 1. Biochimica et Biophysica Acta 2013 1832 10 1463 1472 10.1016/j.bbadis.2013.04.019
22. Zinnanti W. J., Lazovic J., Housman C., Mechanism of metabolic stroke and spontaneous cerebral hemorrhage in glutaric aciduria type I. Acta Neuropathologica Communications 2014 2 1 13
23. Bjugstad K. B., Zawada W. M., Goodman S. I., Freed C. R., IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures. Journal of Inherited Metabolic Disease 2001 24 6 631 647 2-s2.0-0035194446 10.1023/A:1012706908779 (Pubitemid 33130085)
24. Zinnanti W. J., Lazovic J., Wolpert E. B., Antonetti D. A., Smith M. B., Connor J. R., Woontner M., Goodman S. I., Cheng K. C., A diet-induced mouse model for glutaric aciduria type I. Brain 2006 129 4 899 910 2-s2.0-33645087918 10.1093/brain/awl009
25. Marlaire S., van Schaftingen E., Veiga-da-Cunha M., C7orf10 encodes succinate-hydroxymethylglutarate CoA-transferase, the enzyme that converts glutarate to glutaryl-CoA. Journal of Inherited Metabolic Disease 2014 37 1 13 19
26. Sauer S. W., Opp S., Hoffmann G. F., Koeller D. M., Okun J. G., Kölker S., Therapeutic modulation of cerebral l-lysine metabolism in a mouse model for glutaric aciduria type I. Brain 2011 134 1 157 170 2-s2.0-78650692977 10.1093/brain/awq269
27. Strauss K. A., Lazovic J., Wintermark M., Morton D. H., Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency. Brain 2007 130 7 1905 1920 2-s2.0-34447619892 10.1093/brain/awm058 (Pubitemid 47343792)
28. Strauss K. A., Brumbaugh J., Duffy A., Wardley B., Robinson D., Hendrickson C., Tortorelli S., Moser A. B., Puffenberger E. G., Rider N. L., Morton D. H., Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx. Molecular Genetics and Metabolism 2011 104 1-2 93 106 2-s2.0-80052548284 10.1016/j.ymgme.2011.07.003
29. Olivera-Bravo S., Isasi E., Fernández A., White matter injury induced by perinatal exposure to glutaric Acid. Neurotoxicity Research 2014 25 4 381 391
30. Frizzo M. E. S., Schwarzbold C., Porciúncula L. O., Dalcin K. B., Rosa R. B., Ribeiro C. A. J., Souza D. O., Wajner M., 3-Hydroxyglutaric acid enhances glutamate uptake into astrocytes from cerebral cortex of young rats. Neurochemistry International 2004 44 5 345 353 2-s2.0-0344010006 10.1016/S0197-0186(03)00169-4 (Pubitemid 37485866)
31. Olivera-Bravo S., Fernández A., Sarlabós M. N., Rosillo J. C., Casanova G., Jiménez M., Barbeito L., Neonatal astrocyte damage is sufficient to trigger progressive striatal degeneration in a rat model of glutaric Acidemia-I. PLoS ONE 2011 6 6 2-s2.0-79958852822 10.1371/journal.pone. 0020831 e20831
32. Strauss K. A., Donnelly P., Wintermark M., Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency. Brain 2010 133 1 76 92 2-s2.0-74249108469 10.1093/brain/awp297
33. Galluzzi L., Vitale I., Abrams J. M., Alnemri E. S., Baehrecke E. H., Blagosklonny M. V., Dawson T. M., Dawson V. L., El-Deiry W. S., Fulda S., Gottlieb E., Green D. R., Hengartner M. O., Kepp O., Knight R. A., Kumar S., Lipton S. A., Lu X., Madeo F., Malorni W., Mehlen P., Nũez G., Peter M. E., Piacentini M., Rubinsztein D. C., Shi Y., Simon H.-U., Vandenabeele P., White E., Yuan J., Zhivotovsky B., Melino G., Kroemer G., Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death and Differentiation 2012 19 1 107 120 2-s2.0-84255210700 10.1038/cdd.2011.96
34. Varadkar S., Surtees R., Glutaric aciduria type I and kynurenine pathway metabolites: a modified hypothesis. Journal of Inherited Metabolic Disease 2004 27 6 835 842 2-s2.0-7244260428 10.1023/B:BOLI.0000045767.42193.97 (Pubitemid 39433618)
35. Lund T. M., Christensen E., Kristensen A. S., Schousboe A., Lund A. M., On the neurotoxicity of glutaric, 3-hydroxyglutaric, and trans-glutaconic acids in glutaric acidemia type 1. Journal of Neuroscience Research 2004 77 1 143 147 2-s2.0-3042805002 10.1002/jnr.20136 (Pubitemid 38850064)
36. + dependence of 3-hydroxyglutarate-induced excitotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatric Research 2002 52 2 199 206 2-s2.0-0035992221 10.1203/01.PDR.0000023176.89966.45 (Pubitemid 34830391)
37. Dalcin K. B., Rosa R. B., Schmidt A. L., Winter J. S., Leipnitz G., Dutra-Filho C. S., Wannmacher C. M. D., Porciúncula L. O., Souza D. O., Wajner M., Age and brain structural related effects of glutaric and 3-hydroxyglutaric acids on glutamate binding to plasma membranes during rat brain development. Cellular and Molecular Neurobiology 2007 27 6 805 818 2-s2.0-34748875884 10.1007/s10571-007-9197-2 (Pubitemid 47476614)
38. Kölker S., Ahlemeyer B., Krieglstein J., Hoffmann G. F., Maturation-dependent neurotoxicity of 3-hydroxyglutaric and glutaric acids in vitro: a new pathophysiologic approach to glutaryl-CoA dehydrogenase deficiency. Pediatric Research 2000 47 4 495 503 2-s2.0-0342424353 (Pubitemid 30183225)
39. Lagranha V. L., Matte U., de Carvalho T. G., Increased glutamate receptor and transporter expression in the cerebral cortex and striatum of gcdh-/- mice: possible implications for the neuropathology of glutaric acidemia type I. PLoS ONE 2014 9 3 e90477